Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$20.00 – $20.00
Exchange
Grey Market
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.4M | $4.0M | $7.0M | $5.3M | $5.8M | $6.1M | $9.1M | $51.4M |
| Cost of revenue | $0 | $1.4M | $1.4M | $295.0K | $0 | $0 | $0 | $0 |
| Gross profit | $13.4M | $2.7M | $5.6M | $5.0M | $5.8M | $6.1M | $9.1M | $51.4M |
| Gross margin | 100.0% | 65.9% | 79.8% | 94.4% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $13.4M | $15.8M | $22.5M | $16.3M | $10.8M | $12.0M | $13.2M | $13.6M |
| Operating income | −$4.1M | −$15.0M | −$20.9M | −$18.1M | −$12.4M | −$13.3M | −$11.6M | $26.2M |
| EBITDA | −$4.0M | −$14.8M | −$19.4M | −$17.2M | −$11.8M | −$13.3M | −$11.8M | $25.9M |
| Net income | −$5.3M | −$15.0M | −$20.2M | −$21.0M | −$14.9M | −$17.5M | −$16.2M | $15.8M |
| Net margin | -39.3% | -373.5% | -287.1% | -399.4% | -258.6% | -287.1% | -179.1% | 30.8% |
| EPS (diluted) | -0.32 | -0.84 | -1.13 | -1.18 | -0.84 | -0.98 | -0.91 | 0.85 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $9M | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $39M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
NEWRON PHARMS SPA ORD
No one on the platform currently holds NWPHF.
No tracked institution reports a position in NWPHF as of their last filing.
No one on the platform has traded NWPHF yet.
| $255M |
| — |
| FPHAFFaron Pharmaceuticals Oy | $3.30 | +0.00% | $210M | — |
| GUERFGuerbet S.A. | $22.25 | +0.00% | $281M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$NWPHF Come on FDA, giv us the answer , lets move on.
View on StockTwits ↗$NWPHF Researchers at the University of Pittsburgh confirmed that evenamide is a selective voltage-gated sodium channel (VGSC) blocker that specifically targets hippocampal hyperexcitability and normalizes aberrant glutamate release. Unlike traditional antipsychotics, this mechanism addresses positive, negative, and cognitive symptoms in schizophrenia without interacting with dopamine receptors.
View on StockTwits ↗$NWPHF As soon as the FDA Clears this, what Newron is saying the medicien has nothing to do with the Death , i am expeccting a 10-15% raise in price,
View on StockTwits ↗$NWPHF might go fishing tomorrow for a few cheap ones
View on StockTwits ↗$NWPHF Pity https://www.newron.com/news-and-media/regulatory-news/newron-reports-pause-enrollment-new-study-participants-us-centers
View on StockTwits ↗$NWPHF At the meetingtoday The motions on the agenda for the extraordinary part of the meeting were not put to vote, due to the required quorum not being reached. Shareholders approved all motions on the agenda for the ordinary part of the AGM. According to, the extraordinary part of the meeting—which typically covers items like capital increases or amendments to bylaws—did not take place because the required quorum was not reached.
View on StockTwits ↗$NWPHF https://www.newron.com/sites/newron-pharma-corp/files/news-and-media/regulatory-news/2026/april%2023/Newron%20press%20release%20AGM%202026%20results%20EN.pdf
View on StockTwits ↗$NWPHF the next step is apparently the Nasdaq, which will be good, will be diluting another 15%, not all are happy.But Nasdaq means a lot more investors when the good news comes end of this year.
View on StockTwits ↗$NWPHF well here is a news letter from one of the investors , his personal opinion, not anything else. In german but very intresting. https://verus.li/newron-nach-dem-start-der-phase-iii/?cookie-state-change=
View on StockTwits ↗$NWPHF well these are the ones who bought the shares , seems like a solid group.Looks good long term. Helmut Fink, 6934 Sulzberg, AT Tobias Scherer , 85445 Oberding, DE Vinita Singhania, 11065 Delhi , IN Bharat Hari Singhania, 11065 Delhi , IN Sunanda Singhania, 11065 Delhi, IN Raghupati Singhania, 11065 Delhi, IN
View on StockTwits ↗$NWPHF https://www.newron.com/news-and-media/regulatory-news/newron-notes-publication-highlighting-clinically-meaningful-benefits
View on StockTwits ↗$NWPHF been a challenging month a high of over CHF30 to close to CHF20.Nothing changed in principal, except some made some good money.
View on StockTwits ↗$NWPHF good start, yesterday another high and this https://www.newron.com/news-and-media/regulatory-news/newron-further-expands-intellectual-property-portfolio-evenamide-new
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.